Because of VHL inactivation, ccRCC represents a paradigm to assess the relationship between Plk1 and HIFs-α, and the impact of Plk1 on ccRCC aggressiveness. The gene discussed is PLK1; the disease is nonpapillary renal cell carcinoma.